tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine

C106H129Br4N25O4 — CID 158455429

About tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine

tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine (PubChem CID 158455429) has the molecular formula C106H129Br4N25O4 and a molecular weight of 2136.98 g/mol. Its IUPAC name is tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine.

Molecular Properties

• Compound Name: tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine
• PubChem CID: 158455429
• Molecular Formula: C106H129Br4N25O4
• Molecular Weight: 2136.98 g/mol
• Exact Mass: 2131.74
• IUPAC Name: tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine
• SMILES: CN(C)c1ccc(C(=O)CBr)cc1.CN(C)c1ccc(C(=O)CBr)cc1.CN(C)c1ccc(C(=O)CBr)cc1.CN(C)c1ccc(C(=O)CBr)cc1.Cc1cc(N)nnc1C.Cc1cc2nc(-c3ccc(N(C)C)cc3)cn2nc1C.Cc1cn2cc(-c3ccc(N(C)C)cc3)nc2c(C)n1.Cc1cn2cc(-c3ccc(N(C)C)cc3)nc2nc1C.Cc1cnc(N)c(C)n1.Cc1cnc(N)nc1C
• InChI: InChI=1S/3C16H18N4.4C10H12BrNO.3C6H9N3/c1-11-9-20-10-15(18-16(20)12(2)17-11)13-5-7-14(8-6-13)19(3)4;1-11-9-20-10-15(18-16(20)17-12(11)2)13-5-7-14(8-6-13)19(3)4;1-11-9-16-17-15(10-20(16)18-12(11)2)13-5-7-14(8-6-13)19(3)4;4*1-12(2)9-5-3-8(4-6-9)10(13)7-11;1-4-3-8-6(7)5(2)9-4;1-4-3-8-6(7)9-5(4)2;1-4-3-6(7)9-8-5(4)2/h3*5-10H,1-4H3;4*3-6H,7H2,1-2H3;3H,1-2H3,(H2,7,8);3H,1-2H3,(H2,7,8,9);3H,1-2H3,(H2,7,9)
• InChIKey: HEMWLDCUAZAUPO-UHFFFAOYSA-N
• XLogP: 20.59
• TPSA: 336.93 Ų
• H-Bond Donors: 3
• H-Bond Acceptors: 29
• Rotatable Bonds: 18
• Heavy Atoms: 139
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2136.98
LogP ≤ 5	20.59
H-Bond Donors ≤ 5	3
H-Bond Acceptors ≤ 10	29

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine?

The IUPAC name of tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine (CID 158455429) is tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine.

What is the SMILES notation for tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine?

The canonical SMILES for tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine is CN(C)c1ccc(C(=O)CBr)cc1.CN(C)c1ccc(C(=O)CBr)cc1.CN(C)c1ccc(C(=O)CBr)cc1.CN(C)c1ccc(C(=O)CBr)cc1.Cc1cc(N)nnc1C.Cc1cc2nc(-c3ccc(N(C)C)cc3)cn2nc1C.Cc1cn2cc(-c3ccc(N(C)C)cc3)nc2c(C)n1.Cc1cn2cc(-c3ccc(N(C)C)cc3)nc2nc1C.Cc1cnc(N)c(C)n1.Cc1cnc(N)nc1C.

What is the InChIKey of tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine?

The InChIKey is HEMWLDCUAZAUPO-UHFFFAOYSA-N. The full InChI is InChI=1S/3C16H18N4.4C10H12BrNO.3C6H9N3/c1-11-9-20-10-15(18-16(20)12(2)17-11)13-5-7-14(8-6-13)19(3)4;1-11-9-20-10-15(18-16(20)17-12(11)2)13-5-7-14(8-6-13)19(3)4;1-11-9-16-17-15(10-20(16)18-12(11)2)13-5-7-14(8-6-13)19(3)4;4*1-12(2)9-5-3-8(4-6-9)10(13)7-11;1-4-3-8-6(7)5(2)9-4;1-4-3-8-6(7)9-5(4)2;1-4-3-6(7)9-8-5(4)2/h3*5-10H,1-4H3;4*3-6H,7H2,1-2H3;3H,1-2H3,(H2,7,8);3H,1-2H3,(H2,7,8,9);3H,1-2H3,(H2,7,9).

What are the key properties of tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine?

tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine has a molecular weight of 2136.98 g/mol, XLogP of 20.59, 18 rotatable bonds, 3 hydrogen bond donors, and 29 hydrogen bond acceptors.

Where does this data come from?

All data for tetrakis(2-bromo-1-[4-(dimethylamino)phenyl]ethanone);4-(6,8-dimethylimidazo[1,2-a]pyrazin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-a]pyrimidin-2-yl)-N,N-dimethylaniline;4-(6,7-dimethylimidazo[1,2-b]pyridazin-2-yl)-N,N-dimethylaniline;3,5-dimethylpyrazin-2-amine;5,6-dimethylpyridazin-3-amine;4,5-dimethylpyrimidin-2-amine is sourced from PubChem (CID 158455429), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).